MarketBeat on MSN
4 reasons Colgate-Palmolive is a no-brainer hold through 2027
Colgate-Palmolive (NYSE: CL) is a buy-and-hold quality stock offering significant incentives to consumer staples investors.
MarketBeat on MSN
Eli Lilly's new drug data sets up a high-stakes 2026
Since early August, the world’s most valuable pharmaceutical stock, Eli Lilly and Company (NYSE: LLY), has put on a stellar ...
The Kraft Heinz Company has appointed Steve Cahillane as CEO effective Jan. 1, 2026, with current CEO Carlos Abrams-Rivera ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results